Figure 4 In the context of gout, a decrease in BA levels leads to attenuated FXR activity, consequently diminishes the inhibitory effect on NLRP3 and NF-B signaling pathways and promotes enhanced activity and expression of intestinal XOD, thereby triggering inflammatory responses and elevated UA levels, which exacerbate the progression of gout ( Figure 4 )
Dose reduction or temporary treatment interruption, followed by slower re-titration, often allows continued therapy with improved tolerance
Overall nearly one in five adults (18%) say at some point they have taken a GLP-1 drug, a class of medications used for weight loss and to treat diabetes, heart disease, and other chronic conditions
This is especially true for long-term semaglutide use
Among those who have taken these drugs, about half (54%) including 53% of those with health insurance say it was either somewhat or very difficult to afford to pay for these drugs, including one in five (22%) who say it was very difficult, including a similar share of adults with health insurance (23%)
While GLP-1 receptor agonists are powerful tools for weight loss, maintaining lean muscle is essential for overall health, metabolism, and long-term results
